Bioestrovet 0.250 mg/ml solution for injection for cattle

国家: 爱尔兰

语言: 英文

来源: HPRA (Health Products Regulatory Authority)

现在购买

下载 产品特点 (SPC)
12-06-2017

有效成分:

Cloprostenol

可用日期:

Vetoquinol UK Limited

ATC代码:

QG02AD90

INN(国际名称):

Cloprostenol

剂量:

0.250 milligram(s)/millilitre

药物剂型:

Solution for injection

处方类型:

POM: Prescription Only Medicine as defined in relevant national legislation

治疗组:

Cattle

治疗领域:

cloprostenol

疗效迹象:

Hormone

授权状态:

Authorised

授权日期:

2017-04-28

产品特点

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Bioestrovet 0.250 mg/ml solution for injection for cattle
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection.
A clear colourless aqueous solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (heifers, cows).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Cattle (heifers, cows):
- Induction of luteolysis allowing resumption of oestrus and ovulation
in cyclic females when used during dioestrus
- Synchronisation of oestrus (within 2 to 5 days) in groups of cyclic
females treated simultaneously
- Treatment of suboestrus and uterine disorders related to a
functioning or persistent corpus luteum (endometritis,
pyometra)
- Treatment of ovarian luteal cysts
- Induction of abortion until day 150 of pregnancy
- Expulsion of mummified foetuses
- Induction of parturition
4.3 CONTRAINDICATIONS
Do not administer to pregnant animals unless the objective is to
terminate the pregnancy.
Do not use in animals with cardiovascular, gastro-intestinal or
respiratory problems.
Do not administer to induce parturition in cattle with suspected
dystocia due to mechanical obstruction or if problems
are expected because of an abnormal position of the foetus.
Do not use in case of hypersensitivity to the active substance or to
any of the excipients.
Do not administer intravenously.
Each ml contains:
ACTIVE SUBSTANCE:
Cloprostenol
0.250 mg
(equivalent to Cloprostenol Sodium)
0.263 mg
EXCIPIENTS:
Chlorocresol
1.00
mg
For the full list of excipients, see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___

                                
                                阅读完整的文件